2022
DOI: 10.1016/j.survophthal.2021.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Sildenafil in ophthalmology: An update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
19
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 196 publications
0
19
0
Order By: Relevance
“…This medication has some ocular complications associated with PDE-5, such as anterior ischemic optic neuropathy(AION), subretinal hemorrhage, central serous chorioretinopathy (CSC) and extraocular muscle paralysis. 1 …”
Section: Discussionmentioning
confidence: 99%
“…This medication has some ocular complications associated with PDE-5, such as anterior ischemic optic neuropathy(AION), subretinal hemorrhage, central serous chorioretinopathy (CSC) and extraocular muscle paralysis. 1 …”
Section: Discussionmentioning
confidence: 99%
“…Still, it is intriguing that both vasoconstrictors such as sympathomimetics and vasopressin and vasodilators such as phosphodiesterase inhibitors (PDIs) and minoxidil are associated with CSC. [ 12 13 14 17 18 19 ]…”
Section: Pathophysiological Mechanismsmentioning
confidence: 99%
“…However, reportedly, these symptoms are typically transient [ 1 ]. A few studies have reported the effects of sildenafil on ocular tissues [ 2 ]; however, a limited number of studies have discussed sildenafil overdose (particularly doses > 1000 mg), and overdose-induced changes in visual function remain largely unknown. In this study, we report the retinal morphology, retinal sensitivity, and electrophysiological evaluation findings on long-term follow-up in a case of sildenafil overdose (2000 mg).…”
Section: Introductionmentioning
confidence: 99%